Virpax Pharmaceuticals Stock (NASDAQ: VRPX) stock price, news, charts, stock research, profile.
Open | $2.500 |
Close | $2.490 |
Volume / Avg. | 25.288K / 25.095K |
Day Range | 2.295 - 2.660 |
52 Wk Range | 2.105 - 11.774 |
Market Cap | $2.858M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 1.71% |
Days to Cover | 1.9 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Virpax Pharmaceuticals (NASDAQ: VRPX) through any online brokerage.
Other companies in Virpax Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), NovaBay Pharmaceuticals (AMEX:NBY), cbdMD (AMEX:YCBD), 60 Degrees (NASDAQ:SXTP) and MyMD Pharmaceuticals (NASDAQ:MYMD).
The latest price target for Virpax Pharmaceuticals (NASDAQ: VRPX) was reported by Maxim Group on Thursday, June 9, 2022. The analyst firm set a price target for 4.00 expecting VRPX to rise to within 12 months (a possible 63.93% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Virpax Pharmaceuticals (NASDAQ: VRPX) is $2.44 last updated Today at May 9, 2024 at 4:41 PM EDT.
There are no upcoming dividends for Virpax Pharmaceuticals.
Virpax Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 21, 2024.
There is no upcoming split for Virpax Pharmaceuticals.
Virpax Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.